These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20347876)
1. Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism. Schneider JS; Tinker JP; Decamp E Behav Brain Res; 2010 Aug; 211(2):236-9. PubMed ID: 20347876 [TBL] [Abstract][Full Text] [Related]
2. Treatment with the noradrenergic alpha-2 agonist clonidine, but not diazepam, improves spatial working memory in normal young rhesus monkeys. Franowicz JS; Arnsten AF Neuropsychopharmacology; 1999 Nov; 21(5):611-21. PubMed ID: 10516957 [TBL] [Abstract][Full Text] [Related]
3. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. Arnsten AF; Cai JX; Goldman-Rakic PS J Neurosci; 1988 Nov; 8(11):4287-98. PubMed ID: 2903226 [TBL] [Abstract][Full Text] [Related]
4. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Arnsten AF; Contant TA Psychopharmacology (Berl); 1992; 108(1-2):159-69. PubMed ID: 1357704 [TBL] [Abstract][Full Text] [Related]
9. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
10. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Jäkälä P; Riekkinen M; Sirviö J; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P Neuropsychopharmacology; 1999 May; 20(5):460-70. PubMed ID: 10192826 [TBL] [Abstract][Full Text] [Related]
11. Selective effects of clonidine and temazepam on attention and memory. Tiplady B; Bowness E; Stien L; Drummond G J Psychopharmacol; 2005 May; 19(3):259-65. PubMed ID: 15888511 [TBL] [Abstract][Full Text] [Related]
12. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Buccafusco JJ; Webster SJ; Terry AV; Kille N; Blessing D Psychopharmacology (Berl); 2009 Jan; 202(1-3):477-85. PubMed ID: 18784917 [TBL] [Abstract][Full Text] [Related]
13. Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model. Decamp E; Schneider JS Brain Res; 2009 Mar; 1262():109-14. PubMed ID: 19368843 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder. Kawaura K; Karasawa J; Chaki S; Hikichi H Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610 [TBL] [Abstract][Full Text] [Related]
15. The effect of alpha-2 adrenergic agonists on memory and cognitive flexibility. Choi Y; Novak JC; Hillier A; Votolato NA; Beversdorf DQ Cogn Behav Neurol; 2006 Dec; 19(4):204-7. PubMed ID: 17159617 [TBL] [Abstract][Full Text] [Related]
16. Actions of alpha-2 noradrenergic agonists on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtype. Franowicz JS; Arnsten AF Psychopharmacology (Berl); 2002 Jul; 162(3):304-12. PubMed ID: 12122489 [TBL] [Abstract][Full Text] [Related]
17. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Birnbaum SG; Podell DM; Arnsten AF Pharmacol Biochem Behav; 2000 Nov; 67(3):397-403. PubMed ID: 11164065 [TBL] [Abstract][Full Text] [Related]
18. Effects of the noradrenergic agonist clonidine on temporal and spatial attention. Nieuwenhuis S; van Nieuwpoort IC; Veltman DJ; Drent ML Psychopharmacology (Berl); 2007 Aug; 193(2):261-9. PubMed ID: 17431591 [TBL] [Abstract][Full Text] [Related]
19. Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine. Middleton HC; Sharma A; Agouzoul D; Sahakian BJ; Robbins TW Psychopharmacology (Berl); 1999 Aug; 145(4):401-11. PubMed ID: 10460317 [TBL] [Abstract][Full Text] [Related]
20. The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease. Riekkinen M; Jäkälä P; Kejonen K; Riekkinen P Neuroscience; 1999; 92(3):983-9. PubMed ID: 10426538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]